Health

FILE PHOTO: The company’s logo is seen at the new cell and gene therapy factory of Swiss drugmaker Novartis in Stein, Switzerland, November 28, 2019. REUTERS/Arnd Wiegmann ZURICH (Reuters) – Swiss drugmaker Novartis on Monday said it is jettisoning what it had hoped would be a billion-dollar-selling asthma drug, fevipiprant, from its development program after
0 Comments
FILE PHOTO: Nov 2, 2019; Arcadia, CA, USA; Irad Ortiz Jr. aboard Vino Rosso (10) races in the Longines Breeders’ Cup Classic in the 36th Breeders Cup world championships at Santa Anita Park. Mandatory Credit: Richard Mackson-USA TODAY Sports/File Photo (Reuters) – Santa Anita Park, where 35 horses have died as the result of injuries
0 Comments
(Reuters) – U.S. health regulators on Friday approved expanding the heart benefit claims Amarin Corp can make in promoting its drug Vascepa to include reducing the risk of heart attacks and strokes in high-risk patients, opening a multibillion-dollar market opportunity. FILE PHOTO: The corporate logo of the U.S. Food and Drug Administration (FDA) is shown
0 Comments
(Reuters) – Independent advisers to the U.S. Food and Drug Administration on Friday voted unanimously in favor of Horizon Therapeutics Plc’s experimental treatment for active thyroid eye disease, taking the drug closer towards potential approval. If approved, teprotumumab, a type of immunotherapy, is expected to become a standard of care for the vision-threatening autoimmune disorder,
0 Comments
(Reuters Health) – Adolescents who are active on social media may be more likely to exercise excessively, skip meals or develop other forms of disordered eating, a U.S. study suggests. Researchers surveyed 996 seventh- and eighth-graders, age 13 on average, about their use of social media platforms like Facebook, Instagram, Snapchat and Tumbler. They also
0 Comments
(Reuters) – Shares of Sarepta Therapeutics Inc (SRPT.O) soared 31% on Friday after U.S. regulators shocked Wall Street by approving the company’s treatment for a muscle-wasting disorder less than four months after rejecting the drug over safety concerns. FILE PHOTO: The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring,
0 Comments
(Reuters) – Biogen Inc said on Friday it would discontinue development of its experimental therapy for a rare brain disease after the treatment failed a mid-stage trial. The therapy, gosuranemab, failed to hit statistical significance in its main goal and did not demonstrate effectiveness on key secondary goals when tested in patients with progressive supranuclear
0 Comments
FILE PHOTO: Costa Rica’s President Carlos Alvarado Quesada gives a statement to the media at the Chancellery in Berlin, Germany, May 27, 2019. REUTERS/Fabrizio Bensch SAN JOSE (Reuters) – Costa Rica’s President Carlos Alvarado on Thursday issued a technical decree that will allow for therapeutic abortions in the Central American nation, despite opposition from religious
0 Comments
FILE PHOTO: The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland November 4, 2009. REUTERS/Jason Reed/File Photo (Reuters) – The U.S. Food and Drug Administration on Thursday granted an early approval to Sarepta Therapeutics Inc’s second treatment for Duchenne muscular dystrophy (DMD). The company’s shares surged about 28%
0 Comments
(Reuters) – Activist investor Starboard Value LP is pushing healthcare service provider Mednax Inc to sell all or part of itself, reported the Wall Street Journal citing people familiar with the matter. Starboard, which acquired a sizable stake in the company, has privately nominated a majority slate of directors for Mednax’s board. Mednax is in
0 Comments
(Reuters Health) – Although most summer camps welcome kids with food allergies, they often don’t require individualized emergency plans from these campers, a U.S. study suggests. Researchers surveyed 559 leaders at 258 summer camps about food allergy policies, training, medication availability, anaphylaxis events, and confidence in staff to recognize and treat anaphylaxis – a potentially
0 Comments
FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse of an employee in Le Passage, near Agen, France March 29, 2018. REUTERS/Regis Duvignau (Reuters) – Bluebird bio Inc and Bristol-Myers Squibb Co on Monday reported encouraging initial data from an ongoing early-stage study testing their experimental therapy for multiple myeloma
0 Comments
LONDON (Reuters) – A deadly virus called Nipah carried by bats has already caused human outbreaks across South and South East Asia and has “serious epidemic potential”, global health and infectious disease specialists said on Monday. The virus, identified in 1999 in Malaysia and Singapore, has sparked outbreaks with mortality rates of between 40% and
0 Comments